![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 34886 |
FusionGeneSummary for SMG1_CHP1 |
![]() |
Fusion gene information | Fusion gene name: SMG1_CHP1 | Fusion gene ID: 34886 | Hgene | Tgene | Gene symbol | SMG1 | CHP1 | Gene ID | 23049 | 26973 |
Gene name | SMG1, nonsense mediated mRNA decay associated PI3K related kinase | cysteine and histidine rich domain containing 1 | |
Synonyms | 61E3.4|ATX|LIP | CHP1 | |
Cytomap | 16p12.3 | 11q14.3 | |
Type of gene | protein-coding | protein-coding | |
Description | serine/threonine-protein kinase SMG1PI-3-kinase-related kinase SMG-1SMG1 phosphatidylinositol 3-kinase-related kinaselambda-interacting proteinlambda/iota protein kinase C-interacting proteinsmg-1 homolog, phosphatidylinositol 3-kinase-related kinase | cysteine and histidine-rich domain-containing protein 1CHORD-containing protein 1CHP-1chord domain-containing protein 1cysteine and histidine-rich domain (CHORD) containing 1cysteine and histidine-rich domain (CHORD)-containing, zinc-binding protein | |
Modification date | 20180523 | 20180519 | |
UniProtAcc | Q96Q15 | Q99653 | |
Ensembl transtripts involved in fusion gene | ENST00000389467, ENST00000446231, ENST00000565224, ENST00000567737, | ENST00000558351, ENST00000334660, ENST00000560397, | |
Fusion gene scores | * DoF score | 14 X 10 X 7=980 | 5 X 5 X 2=50 |
# samples | 16 | 10 | |
** MAII score | log2(16/980*10)=-2.61470984411521 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/50*10)=1 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SMG1 [Title/Abstract] AND CHP1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SMG1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 11544179 |
Hgene | SMG1 | GO:0018105 | peptidyl-serine phosphorylation | 11544179|15175154 |
Hgene | SMG1 | GO:0046777 | protein autophosphorylation | 11331269|11544179 |
Hgene | SMG1 | GO:0046854 | phosphatidylinositol phosphorylation | 11331269 |
Hgene | SMG1 | GO:2001020 | regulation of response to DNA damage stimulus | 15175154 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BE615097 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + | ||
ChiTaRS3.1 | BE616436 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000389467 | ENST00000558351 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-3UTR | ENST00000389467 | ENST00000334660 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-intron | ENST00000389467 | ENST00000560397 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-intron | ENST00000446231 | ENST00000558351 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-3UTR | ENST00000446231 | ENST00000334660 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-intron | ENST00000446231 | ENST00000560397 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-intron | ENST00000565224 | ENST00000558351 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-3UTR | ENST00000565224 | ENST00000334660 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-intron | ENST00000565224 | ENST00000560397 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-intron | ENST00000567737 | ENST00000558351 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-3UTR | ENST00000567737 | ENST00000334660 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
intron-intron | ENST00000567737 | ENST00000560397 | SMG1 | chr16 | 18819376 | - | CHP1 | chr15 | 41573322 | + |
Top |
FusionProtFeatures for SMG1_CHP1 |
![]() |
Hgene | Tgene |
SMG1 | CHP1 |
Serine/threonine protein kinase involved in both mRNAsurveillance and genotoxic stress response pathways. Recognizesthe substrate consensus sequence [ST]-Q. Plays a central role innonsense-mediated decay (NMD) of mRNAs containing premature stopcodons by phosphorylating UPF1/RENT1. Recruited by release factorsto stalled ribosomes together with SMG8 and SMG9 (forming theSMG1C protein kinase complex), and UPF1 to form the transient SURF(SMG1-UPF1-eRF1-eRF3) complex. In EJC-dependent NMD, the SURFcomplex associates with the exon junction complex (EJC) throughUPF2 and allows the formation of an UPF1-UPF2-UPF3 surveillancecomplex which is believed to activate NMD. Also acts as agenotoxic stress-activated protein kinase that displays somefunctional overlap with ATM. Can phosphorylate p53/TP53 and isrequired for optimal p53/TP53 activation after cellular exposureto genotoxic stress. Its depletion leads to spontaneous DNA damageand increased sensitivity to ionizing radiation (IR). May activatePRKCI but not PRKCZ. {ECO:0000269|PubMed:11331269,ECO:0000269|PubMed:11544179, ECO:0000269|PubMed:15175154,ECO:0000269|PubMed:16452507}. | Calcium-binding protein involved in different processessuch as regulation of vesicular trafficking, plasma membraneNa(+)/H(+) exchanger and gene transcription. Involved in theconstitutive exocytic membrane traffic. Mediates the associationbetween microtubules and membrane-bound organelles of theendoplasmic reticulum and Golgi apparatus and is also required forthe targeting and fusion of transcytotic vesicles (TCV) with theplasma membrane. Functions as an integral cofactor in cell pHregulation by controlling plasma membrane-type Na(+)/H(+) exchangeactivity. Affects the pH sensitivity of SLC9A1/NHE1 by increasingits sensitivity at acidic pH. Required for the stabilization andlocalization of SLC9A1/NHE1 at the plasma membrane. Inhibitsserum- and GTPase-stimulated Na(+)/H(+) exchange. Plays a role asan inhibitor of ribosomal RNA transcription by repressing thenucleolar UBF1 transcriptional activity. May sequester UBF1 in thenucleoplasm and limit its translocation to the nucleolus.Associates to the ribosomal gene promoter. Acts as a negativeregulator of the calcineurin/NFAT signaling pathway. Inhibits NFATnuclear translocation and transcriptional activity by suppressingthe calcium-dependent calcineurin phosphatase activity. Alsonegatively regulates the kinase activity of the apoptosis-inducedkinase STK17B. Inhibits both STK17B auto- and substrate-phosphorylations in a calcium-dependent manner.{ECO:0000269|PubMed:10593895, ECO:0000269|PubMed:11350981,ECO:0000269|PubMed:15035633, ECO:0000269|PubMed:8901634}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SMG1_CHP1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for SMG1_CHP1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SMG1_CHP1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | CHP1 | Q99653 | DB11093 | Calcium Citrate | Calcineurin B homologous protein 1 | small molecule | approved |
Tgene | CHP1 | Q99653 | DB11348 | Calcium Phosphate | Calcineurin B homologous protein 1 | small molecule | approved |
Top |
RelatedDiseases for SMG1_CHP1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |